¿Por indicación clínica o reemplazo sistemático? | 15 OCT 12

¿Cuándo se debe reemplazar un catéter intravenoso periférico?

El reemplazo de los catéteres IV por indicación clínica es seguro, siendo un enfoque actualmente muy difundido en la práctica en todo el mundo.
Autor/a: Dres. C M Rickard, J Webster, M C Wallis, N Marsh, J R Gowardman, L Zhang, M Whitby Lancet 2012; 380: 1066–74
INDICE:  1. Artículo | 2. Artículo
Artículo

Referencias

1 Maki DG. Improving the safety of peripheral intravenous catheters.
2 Zingg W, Pittet D. Peripheral venous catheters: an under-evaluated problem. Int J Antimicrob Agents 2009; 34: S38–42.
3 Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with diff erent intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006; 81: 1159–71.
4 O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011; 52: e162–93.
5 Cook D, Randolph AG, Kernerman P, et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 1997; 25: 1417–24.
6 Bregenzer T, Conen D, Sakmann P, Widmer AF. Is routine replacement of peripheral intravenous catheters necessary?
Arch Intern Med 1998; 158: 151–56.
7 Cornely OA, Bethe U, Pauls R, Waldschmidt D. Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation. Infect Control Hosp Epidemiol 2002; 23: 249–53.
8 Grune F, Schrappe M, Basten J, Wenchel H, Tual E, Stutzer H. Phlebitis rate and time kinetics of short peripheral IV catheters. Infection 2004; 32: 30–32.
9 Rickard CM, McCann D, Munnings J, McGrail MR. Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial. BMC Med 2010; 8: 53.
10 Van Donk P, Rickard CM, McGrail MR, Doolan G. Routine replacement versus clinical monitoring of peripheral intravenous catheters in a regional hospital in the home program: a randomized controlled trial. Infect Control Hosp Epidemiol 2009; 30: 915–17.
11 Webster J, Clarke S, Paterson D, et al. Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial. BMJ 2008; 337: a339.
12 Webster J, Lloyd S, Hopkins T, Osborne S, Yaxley M. Developing a Research base for Intravenous Peripheral cannula re-sites (DRIP trial). A randomised controlled trial of hospital in-patients. Int J Nurs Stud 2007; 44: 664–71.
13 Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. Ann Intern Med 1991; 114: 845–54.
14 O’Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002; 23: 759–69.
15 Maki DG, Weise CE, Sarafi n HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977; 296: 1305–09.
16 Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ 2000; 320: 1197–200.
17 Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters: gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA 1987; 258: 2396–403.
18 Lee WL, Chen HL, Tsai TY, et al. Risk factors for peripheral intravenous catheter infection in hospitalized patients: a prospective study of 3165 patients. Am J Infect Control 2009; 37: 683–86.
19 Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1–45. BMJ 2008; 337: 122–23.
20 Elliott TSJ, Moss HA, Tebbs SE, et al. Novel approach to investigate a source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis 1997; 16: 210–13.
21 Zhang L, Gowardman J, Rickard C. Impact of microbial attachment on intravascular catheter-related infections. Int J Antimicrob Agents 2011; 38: 9–15.
22 Schultz AA, Gallant P. Evidence-based quality improvement project for determining appropriate discontinuation of peripheral IV cannulas. Evid Based Nurs 2005; 8: 8.
23 Palese A, Cassone A, Kulla A, et al. Factors infl uencing nurses’ decision-making process on leaving in the peripheral intravascular catheter after 96 hours: a longitudinal study. J Infus Nurs 2011;34: 319–26.
24 Bravery K, Dougherty L, Gabriel J, Kayley J, Malster M, Scales K. Audit of peripheral venous cannulae by members of an IV therapy forum. Br J Nurs 2006; 15:1244–49.
25 Johansson M, Pilhammar E, Willman A. Nurses’ clinical reasoning concerning management of peripheral venous cannulae. J Clin Nurs 2009; 18:366–75.
26 Gaukroger PB, Roberts JG, Manners TA. Infusion thrombophlebitis: a prospective comparison of 645 Vialon and Tefl on cannulae in anaesthetic and postoperative use. Anaesth Intensive Care 1988; 16: 265–71.
27 Bausone-Gazda D, Lefaiver CA, Walters C-A. A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter-stabilization systems. J Infus Nurs 2010;33: 371–84.
28 Schears GJ. Summary of product trials for 10,164 patients: comparing an intravenous stabilizing device to tape. J Infus Nurs 2006; 29: 225–31.
29 Gallant P, Schultz AA. Evaluation of a visual infusion phlebitis scale for determining appropriate discontinuation of peripheral intravenous catheters. J Infus Nurs 2006; 29: 338–45.
30 Malach T, Jerassy Z, Rudensky B, et al. Prospective surveillance of phlebitis associated with peripheral intravenous catheters. Am J Infect Control 2006; 34: 308–12.
31 Powell J, Tarnow KG, Perucca R. The relationship between peripheral intravenous catheter indwell time and the incidence of phlebitis. J Infus Nurs 2008; 31: 39–45.
32 Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998;158: 473–77.
33 Chico-Padron RM, Carrion-Garcia L, Delle-Vedove-Rosales L, et al. Comparative safety and costs of transparent versus gauze wound dressings in intravenous catheterization. J Nurs Care Qual 2011;26:371–76.
34 Smith B. Peripheral intravenous catheter dwell times. A comparison of 3 securement methods for implementation of a 96-hour scheduled change protocol. J Infus Nurs 2006; 29: 14–17.
35 Webster J, Osborne S, Rickard C, Hall J. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev 2010; 17: CD007798.
 

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024